Risk Factors of Preterm Birth Born in Hospital:a Prospective Multicenter Case-control Study (RFPTB)

March 24, 2019 updated by: Children's Hospital of Fudan University
The purpose of this study is to explore the perinatal risk factors of preterm birth in China.

Study Overview

Status

Completed

Conditions

Detailed Description

Preterm birth is a global scourge, and the leading cause of newborn deaths (babies in the first 4 weeks of life) and raised to the leading cause of death among children under 5 years of age, responsible for approximately 1 million deaths in 2015. In China, the prevalence of preterm increased from 4~5% in 1990s to 7~10% in 2010. Preterm birth become a burden to both the family and society. Therefore, the risk factors of preterm birth become the critical issue of both Obstetrics and Neonatology. More importantly, few multicenter prospective studies on risk factors of preterm birth included potential reasons such as maternal occupation, psychology condition and lifestyles during pregnancy were conducted in China. Thus, the aim of our study is to explore the perinatal risk factors of preterm birth nowadays in China.

Study Type

Observational

Enrollment (Actual)

6000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Fujian
      • Xiamen, Fujian, China, 361000
        • Xiamen Maternal and Child Health Care Hospital
    • Guangdong
      • Guangzhou, Guangdong, China, 510260
        • The Second Affiliated Hospital of Guangzhou Medical University
    • Hainan
      • Haikou, Hainan, China, 570206
        • The Maternal and Child Health Hospital of Hainan Province
    • Henan
      • Zhengzhou, Henan, China, 450052
        • The First Affiliated Hospital of Zhengzhou University
    • Jiangsu
      • Changzhou, Jiangsu, China, 213003
        • Changzhou Maternal And Child Health Care Hospital
      • Nanjing, Jiangsu, China, 210029
        • Jiangsu Province Hospital
    • Ningxia
      • Wuzhong, Ningxia, China, 751300
        • Tongxin County People's Hospital
      • Yingchuan, Ningxia, China, 750001
        • The First People's Hospital of Yinchuan
    • Shandong
      • Binzhou, Shandong, China, 256603
        • Binzhou Medical University Hospital
      • Jining, Shandong, China, 272011
        • Jining No.1 People's Hospital
      • Qingdao, Shandong, China, 266003
        • Affiliated Hospital of Qingdao University
      • Qingdao, Shandong, China, 266200
        • Qingdao Jimo People's Hospital
    • Shanghai
      • Shanghai, Shanghai, China, 200011
        • Obstetrics and Gynecology Hospital of Fudan University
      • Shanghai, Shanghai, China, 201620
        • Songjiang Maternity & Child Health Hospital of Shanghai
    • Zhejiang
      • Wenzhou, Zhejiang, China, 325600
        • Yueqing Hospital Affiliated to Wenzhou Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 4 weeks (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Live-born preterm infants and one term infants born following the preterm infants in the same cooperation hospitals

Description

Inclusion Criteria:

  • Live-born infants >20weeks of gestational age

Exclusion Criteria:

  • Stillbirth

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Preterm group
All the live-born infants with gestational age less than 37weeks and more than 20weeks born in the cooperative hospital every day or every two or three days.
Term group
The one next-live-born infants with gestational age at 37weeks or more than 37weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
live-born preterm
Time Frame: at birth
less than 37weeks gestational age
at birth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
birth weight (g)
Time Frame: at birth
Infant's weight recorded at the time of birth
at birth
gestation age (week)
Time Frame: at birth
the number of completed weeks of gestation, which was determined by the duration of menorrhoea or confirmed by an early ultrasound scan during pregnancy
at birth
Apgar score
Time Frame: 1min after birth
determined by evaluating the newborn baby on five simple criteria(Appearance, Pulse, Grimace, Activity, Respiration) on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10.
1min after birth
Apgar score
Time Frame: 5min after birth
determined by evaluating the newborn baby on five simple criteria(Appearance, Pulse, Grimace, Activity, Respiration) on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10.
5min after birth
small for gestational age
Time Frame: at birth
a birth weight below the 10th percentile for the gestational age
at birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Chen Chao, PhD, MD, Children's Hospital of Fudan University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Actual)

December 31, 2018

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

July 19, 2018

First Submitted That Met QC Criteria

July 19, 2018

First Posted (Actual)

July 27, 2018

Study Record Updates

Last Update Posted (Actual)

March 26, 2019

Last Update Submitted That Met QC Criteria

March 24, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Risk Factors

Subscribe